Cargando…
Unique epigenetic gene profiles define human breast cancers with poor prognosis
Epigenetic enzymes are at the nexus of cellular regulatory cascades and can drive cancer-specific deregulation at all stages of the oncogenic process, yet little is known about their prognostic value in human patients. Here, we used qRT-PCR to profile at high resolution the expression of fifty-five...
Autores principales: | Peña-Llopis, Samuel, Wan, Yihong, Martinez, Elisabeth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349877/ https://www.ncbi.nlm.nih.gov/pubmed/27863398 http://dx.doi.org/10.18632/oncotarget.13334 |
Ejemplares similares
-
Defining a Unique Gene Expression Profile in Mature and Developing Keloids
por: Zhu, Yuan O., et al.
Publicado: (2023) -
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019) -
Epigenetic activation of LY6K predicts the presence of metastasis and poor prognosis in breast carcinoma
por: Kong, Hyun Kyung, et al.
Publicado: (2016) -
Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis
por: Chan, Timothy A, et al.
Publicado: (2008) -
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022)